BioSpace News Archive

ClearMind Biomedical has received FDA clearance for its novel neuroendoscope, the Axonpen System, for illumination and visualization of intracranial tissue and fluids, and the controlled aspiration of tissue and/or fluid during surgery. Requiring only a narrow channel of 6.5mm through the skull for insertion into the br

Tiziana Life Sciences plc (NASDAQ: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announced that it is participating in the J.P. Morgan 39th Annual Healthcare Conference 2021. Dr. Kunwar Shailubhai, CEO and CSO of Tiziana Life Sciences, commented, “I look forward to sharing our exciting story with conference attendees. W

AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, announced that it will present three oral presentations and one poster presentation during the Transplantation & Cellular Therapy Meeting of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) taking place virtually February 8 – 12, 2021.

Genalyte, a leading diagnostics and analytics company, announced the closure of $50 million in financing.

IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary unaudited operational and financial results for the fourth quarter and full year ended January 2, 2021. Fourth Quarter 2020 Total revenue expected to be $12.2 million to $12.4 million, versus $11.8 million in the fourth quarter of 2019 Cash and cash equivalents of approximately $11.6 million as of January 2, 2021, representing a net cash burn of $0.3 million in the fourt

Technologies include In-Sleep Target Memory Consolidation Technology, Handheld Skin Quality Optical Coherence Tomography, Handheld Ultrasound System, Measurement Technique for Lumbar Spine X-Ray Images, and AI Decision Support Technology of Fundus Image in Diabetes Mellitus

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for the fourth quarter and full year 2020 after the market closes on Wednesday, February 3

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today reported unaudited preliminary revenue for the fourth quarter and full year ended December 31, 2020. Personalis estimates revenue of approximately $20.2 million for the fourth quarter of 2020 compared with $18.2 million in the fourth quarter of 2019, representing an increase of 11%. For the full year 2020, r

Revelation Biosciences Inc. (Revelation), a clinical stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease, announced today the appointment of Curt LaBelle, M.D. to the Company’s Board of Directors (Board).

GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary operational and financial results for the year ended December 31, 2020. Financial Highlights Total revenue for 2020 is expected to be approximately $171 million, representing an increase of approximately 95% over 2019 ePlex ® revenue for the full year 2020 is expected to be approximatel